Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 26.81 CNY 1.21% Market Closed
Market Cap: ¥11.2B

Operating Margin

15.6%
Current
Declining
by 12.9%
vs 3-y average of 28.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.6%
=
Operating Income
¥235m
/
Revenue
¥1.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.6%
=
Operating Income
¥235m
/
Revenue
¥1.5B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
11.2B CNY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.3B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...

Market Distribution

Higher than 81% of companies in China
Percentile
81st
Based on 8 544 companies
81st percentile
15.6%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Liaoning Chengda Biotechnology Co Ltd
Glance View

Market Cap
11.2B CNY
Industry
Biotechnology

Liaoning Chengda Biotechnology Co., Ltd. is engaged in the research, development, manufacture and sale of vaccines. The company is headquartered in Shenyang, Liaoning and currently employs 1,663 full-time employees. The company went IPO on 2021-10-28. The firm's main products include rabies vaccine for human use, freeze-dried rabies vaccine for human use, inactivated Japanese encephalitis vaccine for human use and freeze-dried encephalitis inactivated vaccine. The firm's products include two brands: Chengda Suda and Chengda Libao.

Intrinsic Value
20.4 CNY
Overvaluation 24%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
15.6%
=
Operating Income
¥235m
/
Revenue
¥1.5B
What is Liaoning Chengda Biotechnology Co Ltd's current Operating Margin?

The current Operating Margin for Liaoning Chengda Biotechnology Co Ltd is 15.6%, which is below its 3-year median of 28.5%.

How has Operating Margin changed over time?

Over the last 3 years, Liaoning Chengda Biotechnology Co Ltd’s Operating Margin has decreased from 41.6% to 15.6%. During this period, it reached a low of 15.6% on Jul 30, 2025 and a high of 41.6% on May 30, 2022.

Back to Top